Model AUR300 - M2 Macrophage Modulation via CD206 Binding
AUR300 is a novel peptide therapeutic that modulates M2 macrophages (a type of white blood cells) via the macrophage mannose receptor CD206. Dysregulation of M2 macrophages drives fibrosis. AUR300 acts to reduce M2 dysregulation and decrease inflammatory cytokines, and therefore may have significant clinical applications for autoimmune and fibrotic diseases. It is anticipated that clinical development for AUR300 will commence during the first half of 2023.
-
Most popular related searches
Customer reviews
No reviews were found for Model AUR300 - M2 Macrophage Modulation via CD206 Binding. Be the first to review!